Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Quest Diagnostics Incorporated (DGX) has updated its financial outlook for full year 2021. The company said COVID-19 molecular testing volumes were stronger than expected through the end of August and are anticipated to continue to be stronger than projected because of the surge of the Delta variant.


RTTNews | Sep 9, 2021 07:01AM EDT

07:00 Thursday, September 9, 2021 (RTTNews.com) - Quest Diagnostics Incorporated (DGX) has updated its financial outlook for full year 2021. The company said COVID-19 molecular testing volumes were stronger than expected through the end of August and are anticipated to continue to be stronger than projected because of the surge of the Delta variant.

For full year 2021, adjusted earnings per share now expected to be $11.65-$12.35 compared to the previous outlook of $10.65-$11.35. Revenues are now expected to be $9.84-$10.09 billion compared to the prior outlook of $9.54-$9.79 billion. Analysts polled by Thomson Reuters expect the company to report profit per share of $11.38 on revenue of $9.79 billion. Analysts' estimates typically exclude special items.

For 2021, the company now expects reported earnings per share to be $12.54-$13.24 compared to the previous outlook of $11.48-$12.18. Cash provided by operations are now expected to be at least $2.0 billion compared to the prior outlook of at least $1.9 billion.

Read the original article on RTTNews ( https://www.rttnews.com/3224395/quest-diagnostics-raises-2021-guidance-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC